sodium cobaltinitrite

Names

[ CAS No. ]:
13600-98-1

[ Name ]:
sodium cobaltinitrite

[Synonym ]:
SODIUM COBALTINITRITE
Sodium Cobaltnitrite
MFCD00003512
EINECS 237-077-7

Chemical & Physical Properties

[ Melting Point ]:
220 °C (dec.)(lit.)

[ Molecular Formula ]:
CoN₆Na₃O₁₂

[ Molecular Weight ]:
403.93600

[ Exact Mass ]:
403.86000

[ PSA ]:
292.89000

[ LogP ]:
1.50360

[ Stability ]:
Stable. Contact with conbustible material may cause fire. Incompatible with strong acids, organic materials, amines.

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: GF9480000

CHEMICAL NAME :: Cobaltate(3-), hexanitro-, trisodium

CAS REGISTRY NUMBER :: 13600-98-1

LAST UPDATED :: 199504

DATA ITEMS CITED :: 3

MOLECULAR FORMULA :: Co-N6-O12.3Na

MOLECULAR WEIGHT :: 403.96

WISWESSER LINE NOTATION :: .NA3.CO.N-O3*6

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 50 mg/kg

SEX/DURATION :: female 10 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)

REFERENCE :: JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- Volume(issue)/page/year: 58,766,1969 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 83349 No. of Facilities: 32 (estimated) No. of Industries: 2 No. of Occupations: 4 No. of Employees: 142 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 83349 No. of Facilities: 10 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 120 (estimated) No. of Female Employees: 120 (estimated)

Safety Information

[ Symbol ]:

GHS03, GHS07, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H272-H315-H317-H319-H334-H335-H351

[ Precautionary Statements ]:
P220-P261-P280-P305 + P351 + P338-P342 + P311

[ Hazard Codes ]:
O: Oxidizing agent;Xn: Harmful;

[ Risk Phrases ]:
R8

[ Safety Phrases ]:
S17-S26-S36/37

[ RIDADR ]:
UN 1479 5.1/PG 2

[ WGK Germany ]:
3

[ RTECS ]:
GF9480000

[ Packaging Group ]:
II

[ Hazard Class ]:
5.1

[ HS Code ]:
2834100000

Customs

[ HS Code ]: 2834100000

Articles

Pseudohalide anions reveal a novel extracellular site for potentiators to increase CFTR function.

Br. J. Pharmacol. 167(5) , 1062-75, (2012)

There is great interest in the development of potentiator drugs to increase the activity of the cystic fibrosis transmembrane conductance regulator (CFTR) in cystic fibrosis. We tested the ability of ...

Indirect atomic absorption spectrometric determination of pindolol, propranolol and levamisole hydrochlorides based on formation of ion-associates with ammonium reineckate and sodium cobaltinitrite.

J. Pharm. Biomed. Anal. 22(2) , 235-40, (2000)

A new simple, accurate, precise and sensitive indirect method for the determination of pindolol HCl (1), propranolol HCl (2) and levamisole HCl (3) using atomic absorption spectrometry has been develo...

Effect of sodium hexanitrocobaltate (III) decomposition on its staining of intracellular potassium ions.

Stain Technol. 65(1) , 15-24, (1990)

The effect was examined of the chemical decomposition of the potassium stain sodium hexanitrocobaltate (III) (SHC), on its ability to produce stain granules of consistent size that could be used to es...

Sodium Cobaltinitrite
sodium,(Z)-4-[(2-amino-3-methylbutanoyl)amino]-3-chloro-5-hydroxy-5-oxopent-2-enoate
sodium lauroamphoacetate
α-Lactalbumin
sodium 2,8,8-trimethyl-3-oxo-1,7-diaza-4-oxabicyclo<3.2.1>octane-6-carboxylate
sodium [[[(heptadecafluorooctyl)sulphonyl]amino]methyl]benzenesulphonate
3-{1-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylpropanoyl]pyrrolidin-3-yl}propanoic acid
(2R)-2-{2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1,3-thiazol-4-yl]acetamido}-3-hydroxypropanoic acid
1-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoyl]-4-methoxypiperidine-4-carboxylic acid
4-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylbutanamido]-2,2-dimethylbutanoic acid
1-{3-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]propanoyl}pyrrolidine-3-carboxylic acid
2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetamido]-4-methoxybenzoic acid
4-[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methylpentanamido]-3-methylbutanoic acid
1-{[2-ethyl-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]methyl}cyclopropane-1-carboxylic acid
3-[N-ethyl-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,2-dimethylpropanamido]butanoic acid
2-(1-{4-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]oxan-4-yl}-N-methylformamido)acetic acid

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.